# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
On September 12, 2025, Ekso Bionics Holdings, Inc. (the "Company") entered into a Secured Promissory Note and Security ...
Lake Street analyst Ben Haynor maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $15...
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of...